Clinton Plan To Keep Medicare Trust Fund Afloat

13 January 1997

US President Bill Clinton has decided not to propose any increases incosts for Medicare beneficiaries, according to Administration officials, but will instead try to cut back payments to hospitals, doctors and others who provide health care to the elderly.

After their support for similar proposals during the last Congress produced major criticisms from the Democrats, Congressional Republicans have indicated that they are unlikely to ask for any increase in premiums or other charges for beneficiaries.

However, according to a report in the New York Times, another battle is currently looming over Pres Clinton's plan to help keep the Medicare trust fund afloat by shifting the cost of home health care, which is the fastest-growing component of Medicare, from one account to another. Under the proposal, most of the cost of home health care for the elderly and disabled would shift from the Hospital Insurance Trust Fund to a separate Medicare account, with unlimited access to general revenue.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight